🇺🇸 FDA
Patent

US 10478449

2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

granted A61KA61K31/713

Quick answer

US patent 10478449 (2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/713